Columbia University

Technology Ventures

Developing a Business Plan and Securing Investors

Distinguished panelists Mark Leuchtenberger, MBA (President, CEO, IRX Therapeutics), Cameron Durrant, MD, MBA (Chairman and CEO, KaloBios Pharmaceuticals), and Ron Newbold, PhD, MBA (VP, External R&D Innovation, Pfizer) discuss the development of a business plan to bring early stage technologies through clinical development and into the marketplace. This fourth lecture of the Translational Therapeutics Seminar Series is moderated by Lorraine Marchand, MBA (Managing Partner, Centricity Health and Adjunct Professor at Columbia Business School).